Serum M30 ve M65 biyobelirteç düzeylerinin metastatik kanser hastalarında kemoterapi yanıtını önceden tahmin etmedeki öneminin araştırılması

Autor: Slocum, Abdul Kadir

Giriş/Amaç: Dolaşımdaki hücre ölümü biyobelirteçleri olan M30 ve M65’in malign hastalıkları erken bir aşamada tespit etmeye, hastanın tedaviye verdiği yanıtı izlemeye ve hastalarda prognozu tahmin etmeye yardımcı olabileceğini d�

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______9763::25ba4797114020a6b75c9d3f089e1512
https://hdl.handle.net/20.500.12713/2245

Clinical research framework proposal for ketogenic metabolic therapy in glioblastoma.

Autor: Duraj T; Biology Department, Boston College, Chestnut Hill, MA, 02467, USA. durajto@gmail.com., Kalamian M; Dietary Therapies LLC, Hamilton, MT, 59840, USA., Zuccoli G; Neuroradiology, Private Practice, Philadelphia, PA, 19103, USA., Maroon JC; Department of Neurological Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, 15213, USA., D'Agostino DP; Department of Molecular Pharmacology and Physiology, University of South Florida Morsani College of Medicine, Tampa, FL, 33612, USA., Scheck AC; Department of Child Health, University of Arizona College of Medicine, Phoenix, Phoenix, AZ, 85004, USA., Poff A; Department of Molecular Pharmacology and Physiology, University of South Florida Morsani College of Medicine, Tampa, FL, 33612, USA., Winter SF; Department of Neurology, Division of Neuro-Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, 02114, USA., Hu J; Cedars-Sinai Cancer, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA., Klement RJ; Department of Radiotherapy and Radiation Oncology, Leopoldina Hospital Schweinfurt, 97422, Schweinfurt, Germany., Hickson A; Rayma Health, Maple Grove, MN, 55311, USA., Lee DC; Biology Department, Boston College, Chestnut Hill, MA, 02467, USA., Cooper I; Ageing Biology and Age-Related Diseases Group, School of Life Sciences, University of Westminster, London, W1W 6UW, UK., Kofler B; Research Program for Receptor Biochemistry and Tumor Metabolism, Department of Pediatrics, University Hospital of the Paracelsus Medical University, Müllner Hauptstr. 48, 5020, Salzburg, Austria., Schwartz KA; Department of Medicine, Michigan State University, East Lansing, MI, 48824, USA., Phillips MCL; Department of Neurology, Waikato Hospital, Hamilton, 3204, New Zealand.; Department of Medicine, University of Auckland, Auckland, 1142, New Zealand., Champ CE; Exercise Oncology & Resiliency Center and Department of Radiation Oncology, Allegheny Health Network, Pittsburgh, PA, 15212, USA., Zupec-Kania B; Ketogenic Therapies LLC, Elm Grove, WI, 53122, USA., Tan-Shalaby J; School of Medicine, University of Pittsburgh, Veteran Affairs Pittsburgh Healthcare System, Pittsburgh, PA, 15240, USA., Serfaty FM; Department of Clinical Medicine, State University of Rio de Janeiro (UERJ), Rio de Janeiro, RJ, 20550-170, Brazil.; Serfaty Clínicas, Rio de Janeiro, RJ, 22440-040, Brazil., Omene E; Department of Oncology, Cross Cancer Institute, Edmonton, AB, T6G 1Z2, Canada., Arismendi-Morillo G; Department of Medicine, Faculty of Health Sciences, University of Deusto, 48007, Bilbao (Bizkaia), Spain.; Facultad de Medicina, Instituto de Investigaciones Biológicas, Universidad del Zulia, Maracaibo, 4005, Venezuela., Kiebish M; BPGbio Inc, Framingham, MA, 01701, USA., Cheng R; Cheng Integrative Health Center, Columbia, SC, 29212, USA., El-Sakka AM; Metabolic Terrain Institute of Health, East Congress Street, Tucson, AZ, 85701, USA., Pflueger A; Pflueger Medical Nephrologyand , Internal Medicine Services P.L.L.C, 6 Nelson Road, Monsey, NY, 10952, USA., Mathews EH; Department of Physiology, Faculty of Health Sciences, University of Pretoria, Pretoria, 0002, South Africa., Worden D; Arizona State University, Tempe, AZ, 85281, USA., Shi H; Department of Gastrointestinal Surgery and Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, 100038, China., Cincione RI; Department of Clinical and Experimental Medicine, University of Foggia, 71122, Foggia, Puglia, Italy., Spinosa JP; Integrative Oncology, Breast and Gynecologic Oncology Surgery, Private Practice, Rue Des Terreaux 2, 1002, Lausanne, Switzerland., Slocum AK; Medical Oncology, ChemoThermia Oncology Center, Istanbul, 34365, Turkey., Iyikesici MS; Department of Medical Oncology, Altınbaş University Bahçelievler Medical Park Hospital, Istanbul, 34180, Turkey., Yanagisawa A; The Japanese College of Intravenous Therapy, Tokyo, 150-0013, Japan., Pilkington GJ; University of Portsmouth, Portsmouth, PO1 2UP, UK., Chaffee A; Department of Neurosurgery, Sir Charles Gairdner Hospital, Perth, 6009, Australia., Abdel-Hadi W; Clinical Oncology Department, Cairo University, Giza, 12613, Egypt., Elsamman AK; Neurosurgery Department, Cairo University, Giza, 12613, Egypt., Klein P; Mid-Atlantic Epilepsy and Sleep Center, 6410 Rockledge Drive, Suite 610, Bethesda, MD, 20817, USA., Hagihara K; Department of Advanced Hybrid Medicine, Graduate School of Medicine, Osaka University, Osaka, 565-0871, Japan., Clemens Z; International Center for Medical Nutritional Intervention, Budapest, 1137, Hungary., Yu GW; George W, Yu Foundation For Nutrition & Health and Aegis Medical & Research Associates, Annapolis, MD, 21401, USA., Evangeliou AE; Department of Pediatrics, Medical School, Aristotle University of Thessaloniki, Papageorgiou Hospital, Efkarpia, 56403, Thessaloniki, Greece., Nathan JK; Dr. DY Patil Medical College, Hospital and Research Centre, Pune, Maharashtra, 411018, India., Smith K; Barrow Neurological Institute, Dignity Health St. Joseph's Hospital and Medical Center, Phoenix, AZ, 85013, USA., Fortin D; Université de Sherbrooke, Sherbrooke, QC, J1K 2R1, Canada., Dietrich J; Department of Neurology, Division of Neuro-Oncology, Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, 02114, USA., Mukherjee P, Seyfried TN; Biology Department, Boston College, Chestnut Hill, MA, 02467, USA. thomas.seyfried@bc.edu.

Publikováno v: BMC medicine [BMC Med] 2024 Dec 05; Vol. 22 (1), pp. 578. Date of Electronic Publication: 2024 Dec 05.

Efficacy of Metabolically Supported Chemotherapy Combined with Ketogenic Diet, Hyperthermia, and Hyperbaric Oxygen Therapy for Stage IV Triple-Negative Breast Cancer.

Autor: İyikesici MS; Medical Oncology, Kemerburgaz University Bahcelievler Medical Park Hospital., Slocum AK; Medical Oncology, Chemothermia Oncology Center., Slocum A; Medical Oncology, Chemothermia Oncology Center., Berkarda FB; Medical Oncology, Chemothermia Oncology Center., Kalamian M; Nutrition Consultant, Dietary Therapies Llc., Seyfried TN; Biology, Boston College.

Publikováno v: Cureus [Cureus] 2017 Jul 07; Vol. 9 (7), pp. e1445. Date of Electronic Publication: 2017 Jul 07.